Orfali May 4
4 · Sigilon Therapeutics, Inc. · Filed Dec 1, 2021
Insider Transaction Report
Form 4
Orfali May
CHIEF MEDICAL OFFICER
Transactions
- Award
Stock Option (Right to Buy)
2021-12-01+80,000→ 80,000 totalExercise: $3.14Exp: 2031-11-30→ Common Stock (80,000 underlying)
Footnotes (1)
- [F1]The option vests as to 25% of the underlying shares of common stock on November 29, 2022, the first anniversary of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each quarter following such date until the option is fully vested.